[Crossref] [PubMed] Mollan SP, Tahrani AA, Sinclair AJ
No settlements have been reached in GLP-1 litigation as of March 2026
Dosage and Administration Administer to beef and dairy cattle by subcutaneous injection, prior to critical times of the production cycle or known stress
Weeks 9-12: 8mg/week Full therapeutic range
or adults with overweight and at least one weight-related health condition such as Type 2 diabetes, high blood pressure, or high cholesterol Lowers the risk of major cardiovascular events in adults with both heart disease and obesity or overweight Common side effects of Wegovy are nausea, vomiting, diarrhea, constipation, stomach pain, indigestion, burping, bloating, gas, headache, tiredness, and dizziness
What approach do you recommend dermatologists take with patients who are either currently on or are considering using GLP-1 agonists